• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

p50(cdc37)直接与Raf的催化结构域结合,也与热休克蛋白90(hsp90)上一个在拓扑结构上与四肽重复序列结合位点相邻的位点结合。

p50(cdc37) binds directly to the catalytic domain of Raf as well as to a site on hsp90 that is topologically adjacent to the tetratricopeptide repeat binding site.

作者信息

Silverstein A M, Grammatikakis N, Cochran B H, Chinkers M, Pratt W B

机构信息

Department of Pharmacology, The University of Michigan Medical School, Ann Arbor, Michigan 48109, USA.

出版信息

J Biol Chem. 1998 Aug 7;273(32):20090-5. doi: 10.1074/jbc.273.32.20090.

DOI:10.1074/jbc.273.32.20090
PMID:9685350
Abstract

Several protein kinases (e.g. pp60(src), v-Raf) exist in heterocomplexes with hsp90 and a 50-kDa protein that is the mammalian homolog of the yeast cell cycle control protein Cdc37. In contrast, unliganded steroid receptors exist in heterocomplexes with hsp90 and a tetratricopeptide repeat (TPR) domain protein, such as an immunophilin. Although p50(cdc37) and TPR domain proteins bind directly to hsp90, p50(cdc37) is not present in native steroid receptor.hsp90 heterocomplexes. To obtain some insight as to how v-Raf selects predominantly hsp90.p50(cdc37) heterocomplexes, rather than hsp90.TPR protein heterocomplexes, we have examined the binding of p50(cdc37) to hsp90 and to Raf. We show that p50(cdc37) exists in separate hsp90 heterocomplexes from the TPR domain proteins and that intact TPR proteins compete for p50(cdc37) binding to hsp90 but a protein fragment containing a TPR domain does not. This suggests that the binding site for p50(cdc37) lies topologically adjacent to the TPR acceptor site on the surface of hsp90. Also, we show that p50(cdc37) binds directly to v-Raf, with the catalytic domain of Raf being sufficient. We propose that the combination of exclusive binding of p50(cdc37) versus a TPR domain protein to hsp90 plus direct binding of p50(cdc37) to Raf allows the protein kinase to select for the dominant hsp90.p50(cdc37) composition that is observed with a variety of protein kinase heterocomplexes immunoadsorbed from cytosols.

摘要

几种蛋白激酶(如pp60(src)、v-Raf)与热休克蛋白90(hsp90)及一种50 kDa的蛋白形成异源复合物,该50 kDa蛋白是酵母细胞周期调控蛋白Cdc37的哺乳动物同源物。相比之下,未结合配体的类固醇受体与hsp90及一种四肽重复(TPR)结构域蛋白(如亲免素)形成异源复合物。虽然p50(cdc37)和TPR结构域蛋白直接与hsp90结合,但天然类固醇受体-hsp90异源复合物中不存在p50(cdc37)。为了深入了解v-Raf如何主要选择hsp90-p50(cdc37)异源复合物,而不是hsp90-TPR蛋白异源复合物,我们研究了p50(cdc37)与hsp90及Raf的结合。我们发现p50(cdc37)与TPR结构域蛋白存在于不同的hsp90异源复合物中,完整的TPR蛋白竞争p50(cdc37)与hsp90的结合,但含有TPR结构域的蛋白片段则不能。这表明p50(cdc37)的结合位点在拓扑结构上与hsp90表面的TPR受体位点相邻。此外,我们还表明p50(cdc37)直接与v-Raf结合,Raf的催化结构域就足够了。我们提出,p50(cdc37)与TPR结构域蛋白对hsp90的排他性结合,加上p50(cdc37)与Raf的直接结合,使得蛋白激酶能够选择出在从胞质溶胶免疫吸附的多种蛋白激酶异源复合物中观察到的主要hsp90-p50(cdc37)组成。

相似文献

1
p50(cdc37) binds directly to the catalytic domain of Raf as well as to a site on hsp90 that is topologically adjacent to the tetratricopeptide repeat binding site.p50(cdc37)直接与Raf的催化结构域结合,也与热休克蛋白90(hsp90)上一个在拓扑结构上与四肽重复序列结合位点相邻的位点结合。
J Biol Chem. 1998 Aug 7;273(32):20090-5. doi: 10.1074/jbc.273.32.20090.
2
p50(Cdc37) can buffer the temperature-sensitive properties of a mutant of Hck.p50(Cdc37)可以缓冲Hck突变体的温度敏感性特性。
Mol Cell Biol. 2000 Sep;20(18):6984-95. doi: 10.1128/MCB.20.18.6984-6995.2000.
3
p50(cdc37) acting in concert with Hsp90 is required for Raf-1 function.Raf-1功能需要p50(cdc37)与Hsp90协同作用。
Mol Cell Biol. 1999 Mar;19(3):1661-72. doi: 10.1128/MCB.19.3.1661.
4
Raf exists in a native heterocomplex with hsp90 and p50 that can be reconstituted in a cell-free system.Raf与hsp90和p50以天然异源复合物的形式存在,该复合物可在无细胞系统中重建。
J Biol Chem. 1993 Oct 15;268(29):21711-6.
5
The hsp90-based chaperone system: involvement in signal transduction from a variety of hormone and growth factor receptors.基于热休克蛋白90的伴侣蛋白系统:参与多种激素和生长因子受体的信号转导。
Proc Soc Exp Biol Med. 1998 Apr;217(4):420-34. doi: 10.3181/00379727-217-44252.
6
Binding of immunophilins to the 90 kDa heat shock protein (hsp90) via a tetratricopeptide repeat domain is a conserved protein interaction in plants.亲免素通过四肽重复结构域与90 kDa热休克蛋白(hsp90)结合,这是植物中一种保守的蛋白质相互作用。
Biochemistry. 1996 Dec 3;35(48):15249-55. doi: 10.1021/bi9615349.
7
A 50 kilodalton protein associated with raf and pp60(v-src) protein kinases is a mammalian homolog of the cell cycle control protein cdc37.一种与raf和pp60(v-src)蛋白激酶相关的50千道尔顿蛋白是细胞周期调控蛋白cdc37的哺乳动物同源物。
Biochemistry. 1997 Mar 25;36(12):3600-7. doi: 10.1021/bi9612529.
8
The native v-Raf.hsp90.p50 heterocomplex contains a novel immunophilin of the FK506 binding class.天然的v-Raf.hsp90.p50异源复合物包含一种新型的FK506结合类免疫亲和素。
J Biol Chem. 1994 Sep 2;269(35):22157-61.
9
p50(cdc37) is a nonexclusive Hsp90 cohort which participates intimately in Hsp90-mediated folding of immature kinase molecules.p50(细胞分裂周期蛋白37)是一种非排他性的热休克蛋白90伴侣蛋白,它密切参与热休克蛋白90介导的未成熟激酶分子的折叠过程。
Biochemistry. 2000 Jun 27;39(25):7631-44. doi: 10.1021/bi000315r.
10
Hsp90 regulates p50(cdc37) function during the biogenesis of the activeconformation of the heme-regulated eIF2 alpha kinase.在血红素调节的eIF2α激酶活性构象的生物合成过程中,热休克蛋白90(Hsp90)调节p50(cdc37)的功能。
J Biol Chem. 2001 Jan 5;276(1):206-14. doi: 10.1074/jbc.M007583200.

引用本文的文献

1
Characterization of MEK1/2 Degraders Uncovers a Kinase-Independent Role for MEK1/2 in the Stabilization and Maturation of CRAF.MEK1/2降解剂的表征揭示了MEK1/2在CRAF稳定和成熟过程中不依赖激酶的作用。
bioRxiv. 2025 Mar 14:2025.03.11.642495. doi: 10.1101/2025.03.11.642495.
2
AURKB/CDC37 complex promotes clear cell renal cell carcinoma progression via phosphorylating MYC and constituting an AURKB/E2F1-positive feedforward loop.AURKB/CDC37 复合物通过磷酸化 MYC 并构成 AURKB/E2F1 正反馈环促进肾透明细胞癌的进展。
Cell Death Dis. 2024 Jun 18;15(6):427. doi: 10.1038/s41419-024-06827-y.
3
Cell Stress Induced Stressome Release Including Damaged Membrane Vesicles and Extracellular HSP90 by Prostate Cancer Cells.
前列腺癌细胞诱导的应激体释放,包括受损的膜囊泡和细胞外 HSP90。
Cells. 2020 Mar 19;9(3):755. doi: 10.3390/cells9030755.
4
MZF1 and SCAND1 Reciprocally Regulate Gene Expression in Prostate Cancer.MZF1和SCAND1相互调节前列腺癌中的基因表达。
Cancers (Basel). 2019 Jun 8;11(6):792. doi: 10.3390/cancers11060792.
5
Computational Discovery of Niclosamide Ethanolamine, a Repurposed Drug Candidate That Reduces Growth of Hepatocellular Carcinoma Cells In Vitro and in Mice by Inhibiting Cell Division Cycle 37 Signaling.氯硝柳胺乙醇胺的计算发现,一种重新利用的候选药物,通过抑制细胞分裂周期37信号通路在体外和小鼠体内降低肝癌细胞的生长。
Gastroenterology. 2017 Jun;152(8):2022-2036. doi: 10.1053/j.gastro.2017.02.039. Epub 2017 Mar 8.
6
Extracellular molecules involved in cancer cell invasion.参与癌细胞侵袭的细胞外分子。
Cancers (Basel). 2015 Jan 26;7(1):238-65. doi: 10.3390/cancers7010238.
7
FW-04-806 inhibits proliferation and induces apoptosis in human breast cancer cells by binding to N-terminus of Hsp90 and disrupting Hsp90-Cdc37 complex formation.FW-04-806通过与热休克蛋白90(Hsp90)的N端结合并破坏Hsp90-Cdc37复合物的形成,抑制人乳腺癌细胞的增殖并诱导其凋亡。
Mol Cancer. 2014 Jun 14;13:150. doi: 10.1186/1476-4598-13-150.
8
Structural bioinformatics and protein docking analysis of the molecular chaperone-kinase interactions: towards allosteric inhibition of protein kinases by targeting the hsp90-cdc37 chaperone machinery.结构生物信息学和蛋白质对接分析分子伴侣-激酶相互作用:通过靶向 HSP90-CDC37 伴侣机制实现蛋白激酶的变构抑制。
Pharmaceuticals (Basel). 2013 Nov 11;6(11):1407-28. doi: 10.3390/ph6111407.
9
Oral administration of an HSP90 inhibitor, 17-DMAG, intervenes tumor-cell infiltration into multiple organs and improves survival period for ATL model mice.口服 HSP90 抑制剂 17-DMAG 可干预肿瘤细胞浸润多个器官,并延长 ATL 模型小鼠的生存时间。
Blood Cancer J. 2013 Aug 16;3(8):e132. doi: 10.1038/bcj.2013.30.
10
Cdc37 (cell division cycle 37) restricts Hsp90 (heat shock protein 90) motility by interaction with N-terminal and middle domain binding sites.Cdc37(细胞分裂周期 37)通过与 N 端和中间结构域结合位点的相互作用限制 Hsp90(热休克蛋白 90)的运动性。
J Biol Chem. 2013 May 31;288(22):16032-42. doi: 10.1074/jbc.M112.439257. Epub 2013 Apr 8.